Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 84.60
-0.90 (-1.05%)
Aug 19, 2026, 1:24 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.32 billion as of August 19, 2026. Its market cap has decreased by -33.20% in one year.
Market Cap
2.32B
Enterprise Value
2.27B
Revenue
2.05B
Ranking
n/a
PE Ratio
10.26
Stock Price
84.60
ChartMarket Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.32B, an increase of 522.88%. That is a compound annual growth rate of 8.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 2.32B | -26.29% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.87B |
| 3D Global Biotech | 2.85B |
| BRIM Biotechnology | 2.71B |
| Chunghwa Chemical Synthesis & Biotech | 2.69B |
| Energenesis Biomedical CO.,LTD. | 2.67B |
| GlycoNex Incorporation | 2.57B |
| HeXun Biosciences | 2.24B |
| Taiwan Bio Therapeutics | 2.19B |